Retinopathy of Prematurity
Focused reporting on ROP screening, diagnosis, and management. Includes updates on guidelines, technology, and neonatal care collaboration.
Three-year FIREFLEYE outcomes reported for aflibercept vs laser in ROP
Children treated with intravitreal aflibercept 0.4 mg for retinopathy of prematurity (ROP) maintained stable disease control and age-appropriate visual function through 3...
Study highlights link between obesity indicators and risk of retinopathy
Multiple obesity indicators are significantly associated with an increased risk of retinopathy, with the weight-adjusted waist index (WWI) showing the strongest predictive...
Declining trends in retinopathy of prematurity screening eligibility among U.S. infants
A recent national study analyzed trends in retinopathy of prematurity (ROP) screening eligibility among U.S. infants from 2003 to 2022, revealing a...
Three-year FIREFLEYE outcomes reported for aflibercept vs laser in ROP
Children treated with intravitreal aflibercept 0.4 mg for retinopathy of prematurity (ROP) maintained stable disease control and age-appropriate visual function through 3 years, with fewer cases of high myopia and...
Study highlights link between obesity indicators and risk of retinopathy
Multiple obesity indicators are significantly associated with an increased risk of retinopathy, with the weight-adjusted waist index (WWI) showing the strongest predictive value, according to a study. Researchers employed weighted...
Declining trends in retinopathy of prematurity screening eligibility among U.S. infants
A recent national study analyzed trends in retinopathy of prematurity (ROP) screening eligibility among U.S. infants from 2003 to 2022, revealing a significant decline in the number of infants meeting...
Shorter axial length and steeper corneas found in preterm children with ROP
Children with a history of retinopathy of prematurity (ROP) exhibit significant differences in biometric parameters, specifically, shorter axial lengths and steeper corneas, according to a study. The study analyzed biometric...
Global survey reveals trends in treatment for retinopathy of prematurity
The use of anti-VEGF therapies is increasingly favored as the first-line treatment for severe cases of retinopathy of prematurity (ROP), according to a study. However, laser therapy remains the preferred...
Early ROP screening urged for extremely premature infants, study finds
Extremely premature infants, particularly those born before 24 weeks’ gestational age, are at significantly higher risk for developing severe retinopathy of prematurity (ROP) early in their postnatal life, according to...
Network meta-analysis compares anti-VEGF agents/doses vs laser for ROP
The findings from a recent network meta-analysis that compared different agents and doses of anti-vascular endothelial growth factors (anti-VEGF) vs laser photocoagulation (LPC) for treatment of retinopathy of prematurity (ROP)...